It was worth noting that the rate of brain metastasis in EGFR positive patients was much higher than that in EGFR negative patients (21.7% vs. 2.8%, p < 0.001), which was similar to the previous results of NSq-NSCLC patients (54). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.